Clinical trial
Reducing Blood Culture Contamination: a Prospective Crossover Study
NCT02754791 is registered in ClinicalTrials.gov with Shaare Zedek Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reducing Blood Culture Contamination: a Prospective Crossover Study
- Lead sponsor
- Shaare Zedek Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2016
- Completion date
- May 31, 2017
- Enrollment
- 1,500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
preventing blood culture contamination